
E
Tier
Plant flavonoid studied as a senolytic (not a peptide).
Longevity & Cellular Health
Plant flavonoid, not a peptide
WADA Status:
Not prohibited
Human Trial Scoreboard
Completed human RCTs
Early phase, pending
Largest Human Study
Size not verified
Longest exposure
Duration not verified
Most Recent Trial
Results pending
Description
Fisetin is not a peptide. It is a flavonoid, a plant compound found in strawberries, apples and onions, and it is one of the more credible senolytic candidates. Senolytics work by selectively killing senescent cells, damaged cells that stop dividing but do not die, instead lingering in tissue and releasing inflammatory signals that appear to drive much of what we experience as ageing. In animal studies fisetin cleared these cells and extended lifespan. What distinguishes it from most things in this database is that the human trials are actually happening, run by the Mayo Clinic and others, several of them registered and ongoing. Results are largely still pending, which is a more honest position than almost anything else here.
What Are The Claims
Claims made for this compound: Senolytic; Anti-inflammatory antioxidant
Evidence
The gap between the trial protocols and the commercial product is unusually concrete here. Human senolytic trials, including AFFIRM at the Mayo Clinic under registry number NCT03430037, plus COVID-FIS and SToMP-AD, use intermittent pulsed dosing: a short course of consecutive days, repeated after an interval of weeks. Commercial fisetin products are sold and labeled for daily use. Those are different interventions. More fundamentally, no published human trial has yet demonstrated a senolytic effect in people. The trials are running and blinded efficacy data remain unpublished. Senolysis in humans is currently a hypothesis under investigation, not a finding, and fisetin is sold as though that question were settled.
Evidence Strength
Animal/preclinical + early human (trials ongoing)
Caveats
Available as a dietary supplement OTC; not FDA-approved as a drug; senolytic evidence is preliminary and largely limited to preclinical models; human trials are early-phase and small.
Safety
Alternative Measures
Legal Status
US
Dietary supplement
UK
Supplement
EU
Supplement
AU
Supplement
WADA
Not prohibited
A flavonoid present in foods including strawberries and apples, sold as a dietary supplement. Not an approved drug and not approved for any senolytic indication.
Citations
AFFIRM trial, NCT03430037, Mayo Clinic, Phase IIb, intermittent pulsed dosing protocol. | COVID-FIS and SToMP-AD trials, pulsed dosing. | No published human trial has demonstrated senolytic effect to date.